Table 5.
Plants | The medical interest of the inventoried plants according to the literature | Ethnopharmacological use |
---|---|---|
Apteranthes europaea (Guss.) Murb. | Cytotoxic activity on MDA-MB-231 and MCF-7 lin cells of breast cancer (Amrati et al., 2020b). | Anti-inflammatory, ulcer, antidiabetic, and anti-bacterial (Adnan et al., 2014) |
Aristolochia longa L. | Apoptogenic activity on Burkitt’s lymphoma BL41 cells (Benarba et al., 2012). |
Abortifacient, sedative, analgesic, anti-inflammatory, anti-feedant, muscle relaxant, antihistaminic, and anti-allergic (Benarba and Meddah, 2014). |
Cytotoxic activity against lymphocytic leukemia (P-388) and bronchial epidermoid carcinoma of human origin (NSCLCN6) (Hinou et al., 1990). | ||
Nigella sativa L. | Anticancer activity on human breast cancer cells: MCF-7 (Periasamy et al., 2016). |
Treatment of rheumatoid arthritis, diabetes, asthma, Obesity, and other metabolic disorders (Namazi et al., 2018). |
Anticancer effect on human lung carcinoma (A549), larynx epidermoid carcinoma (HEp-2), colon adenocarcinoma (HT-29), and pancreas carcinoma (MIA PaCa-2) (Rooney and Ryan, 2005). | ||
Allium sativum L. | Reduction of the frequency progression of colorectal adeno carcinoma (Wargovich, 1987) |
Prevention and treatment of atherosclerosis, cardiovascular, hyperlipidemia, thrombosis, hypertension, microbial infections, diabetes, and asthma (Lyantagaye, 2011). |
Treatment of bladder cancer (Lamm and Riggs, 2000) | ||
Marrubium vulgare L. | Cytotoxic activity against the cervical cancer lines: HeLa cells (Zarai et al., 2011). | Neurosedative and anti-inflammatory (Sahpaz et al., 2002). |
Trigonella foenum-graecum L. | Cytotoxic effect against T-cell lymphoma (Alsemari et al., 2014). | Antidiabetic, carminative, tonic, and antinociceptive (Hamza et al., 2012); (Javan et al., 1997); (Zia et al., 2001). |
Artemisia herba-alba Asso. |
Antiproliferative activity against P815 and BSR kidney carcinoma cell lines (Tilaoui et al., 2015). |
Treatment of infectious diseases, inflammatory disorders (colds, coughing, bronchitis, diarrhea), diabetes, neuralgias, antiseptic and against skin diseases, scabies, syphilis, fever as well as menstrual and nervous disorders (Abu-Darwish et al., 2015). |
Anticancer activity against human bladder carcinoma RT112, and human myelogenous leukemia K562 (Khlifi et al., 2013). | ||
Allium cepa L. | Cytotoxic activity vs. multidrug resistant erythroleukemic cell lines: (Lucena and K562) (Votto et al., 2010). | Blood purifier, infectious diseases, digestive problems, skin diseases, metabolic disease, insect bites (Teshika et al., 2018). |
Apoptosis and suppression of Bcl-2 through inhibition of PI3K/Akt Signaling Pathway in AGS human cancer cells (Lee et al., 2014). | ||
Berberis hispanica Boiss. & Reut. | Apoptotic effect in human laryngeal cancer cells Hep-2 (Boudjlida et al., 2019). | Treatment of gastrointestinal affections, liver inflammation, and biliary disorders (el Hamsas el Youbi, 2011) |
Zingiber officinale Roscoe |
Ameliorate chemotherapy- induced nausea and vomiting (Jagetia et al., 2003). | Treatment of airway infections, nausea, and spasm (Moghaddasi and Haddad Kashani, 2012), (Chang et al., 2013). |
Anticancer activity against human breast carcinoma cell lines (MCF-7 cancer cells and MDA-MB-231 (Rahman et al., 2011). | ||
Effect on cancer cell growth of human Hela cancer cells (Cheng et al., 2011). | ||
Petroselinum crispum (Mill.) Fuss | Induction cell death in MCF-7 cells (Farshori et al., 2013). | Treatment of gastrointestinal disorder, inflammation, halitosis, kidney stone, amenorrhoea, dermatitis, headcool, vision performance, hemorrhoid (Farzaei et al., 2013). |
Reduction of the cell viability of HepG2 (Human Hepatocellular Carcinoma Cells) (Farshori et al., 2014). | ||
Olea europaea L. | Anti-proliferative activity on human leukemic cell line (Jurkat) (Fares et al., 2011). | Hypertension, inflammatory diseases, diabetes, diarrhea, respiratory and urinary tract infections, stomach, intestinal diseases, asthma, and rheumatism (Scheffler et al., 2008), (Song et al., 2019). |
Anti-cancer effect on human BRAF melanoma cells (Ruzzolini et al., 2018). | ||
Curcuma longa L. | Cytotoxic activity against lymphocytes and Dalton's lymphoma cells (Kuttan et al., 1985). | Biliary disorders, anorexia, cough, diabetic wounds, hepatic disorders, rheumatism and sinusitis (Kumar and Sakhya, 2013). |
Anti-tumor activity against Ehrlich ascites tumour (Ruby et al., 1995). | ||
Induction of apoptosis in human cell lung cancer NCI-H460 cells 37 (Wu et al., 2010). | ||
Linum usitatissimum L. | Anticancer effect against Human cervical cancer cell line: Hela cells (Joseph et al., 2020). |
Diarrhea, gastrointestinal infections, asthma, cough, bronchitis, pneumonia, renal colic, renal calculi, rheumatic swelling (Khan et al., 2017). |
Inhibition of Jeg3 cell growth by the phytoestrogens isolated from Linum usitatissimum L. (Abarzua et al., 2007). | ||
Capparis spinosa L. |
Cytotoxic activity against both breast and colon cell lines: MCF-7 and HCT-116 (Aljaiyash et al., 2014). |
The treatment of rheumatism, gout and abdominal pains (Maresca et al., 2016). |
Erodium guttatum (Desf.) Willd. | No data | Wound healing (Helmstädter, 2017). |
Camellia sinensis (L.) Kuntze | Suppression of the growth of prostate cancer (HH870 and DU145) and epithelial ovarian cancer cell lines (HH450 and HH639) (Ravindranath et al., 2006). |
Stimulant, diuretic, astringent, heart health, flatulence, regulating body temperature and blood sugar, promoting digestion, and improving mental processes (Chopade et al., 2008). |
Origanum vulgare L. | Anticancer activity against cervical cancer line: Hella cells (Koldaş et al., 2015). | Treatment of respiratory, cutaneous infections, igestive disorders, headaches, sore throats or colds (Vale-Silva et al., 2012), (de Torre et al., 2020). |
Apoptosis in human colon cancer caco2 cells (Savini et al., 2009). | ||
Salvia officinalis L. | Cytotoxic activity on colon cancer: HCT-116 cells (El Hadri et al., 2010). | Treatment of emmenagogue, cold, throat infections, skin diseases, ulcers, laryngitis, inflammation, bronchitis and Alzheimer’s disease (Sharma et al., 2019). |
Peganum harmala L. | Antitumor effect on Lewis Lung, sarcoma180 and HepA tumor (Chen et al., 2005) | Antihypertensive, blood purifier, Antidiarrheal, intestinal pain, Antispasmodic in colic, Against nervosity, Emmenagogue, antalgic, Antidiabetic, Anti-pyretic (Moloudizargari et al., 2013). |
Antiproliferative effect on leukemic cell line cells of Jurkat (Lamchouri et al., 2013) | ||
Lepidium sativum L. | Apoptosis in human breast cancer cells: MCF-7 cell lines (Mahassni and Al-Reemi, 2013). | Treatment of chronic liver and spleen complaints, inflammatory rheumatic pains, skin diseases, asthma, diarrhea (Divanji et al., 2011). |
Opuntia ficus-indica (L.) Mill. | Anticancer activity on Ehrlich ascites carcinoma cells (Abou-Elella and Ali, 2014). | Treatment of burns, wounds, edema, diabetes, obesity, indigestion, hyperlipidemy, viral and inflammatory infections (Kaur et al., 2012). |
Apoptosis activity in human chronic myeloid leukemia Cell line-K562 (Sreekanth et al., 2007). | ||
Rosmarinus officinalis L. | Antiproliferative effect on human ovarian cancer cells (A2780 and A2780CP70) (Tai et al., 2012). | Analgesic, anti-inflammatory, anti-rheumatic, spasmolytic, carminative and choleretic applications (Minaiyan et al., 2011). |
Anticancer Effect on CaCo-2 colon cancer cells (Moore et al., 2016). | ||
Ficus carica L. | Anti-angiogenic activity on human umbilical vein endothelial cells (Mostafaie et al., 2011) | Treatment of gastrointestinal disorders (colic, indigestion, loss of appetite, and diarrhea), respiratory (sore throats, cough, and bronchial problems), inflammatory, and cardiovascular disorders (Mawa et al., 2013). |
di Punica granatum L. | Induction of apoptosis in prostate cancer cell line (Sineh Sepehr et al., 2012). | Treatment of atherosclerosis, diabetes,hypertension, hyperlipidemia, cancer, peptic ulcer and oral diseases (Ge et al., 2021). |
Anticancer activity on human cancer cell lines melanoma (A375), colon cancer (HCT116), and hepatocellular carcinoma (HepG2) (Joseph et al., 2013). | ||
Cuminum cyminum L. |
Cytotoxic activity against colon cancer cells (502713, Colo-205, Hep-2, A-549, OVCAR-5, PC-5, SF-295) (Prakash and Gupta, 2014). | Treatment of asthma, bronchitis, rheumatism, hypolipidemia, cancer, diabetes and other inflammatory diseases (Mnif and Aifa, 2015), (Srinivasan, 2018). |
Apium graveolens L. | Anticancer activity vs. rhabdomysarcom (RD) and murine (L20B) (AL-Jumaily, 2018). | Treatment of spasm, stomach problems, used also as diuretic, laxative, and sedative, and to lower the blood pressure (Al-Asmari et al., 2017). |
Daucus carota L. |
Antiproliferative effect on human Lymphoid Leukaemia Cells 67 (Zaini et al., 2012). | Treatment of gastric disorders, acidity and gastric ulcers (Nayeem et al., 2010) |
Anticancer effect against human colon (HT‐29, Caco‐2) and breast (MCF‐7, MDA‐MB‐231) cancer cell (Shebaby et al., 2013). | ||
Dittrichia viscosa (L.) | Antiproliferative and apoptosis effects on breast cancer cells (MCF-7) (Talib et al., 2012). | Wound healing, herniated disc, stomachache, anticancer, kidney pain, kidney stones, skin, hair, eye ailments and cancer (Sevgi et al., 2021). |
Sinapis alba L. |
Anticancer effect on colon cancer cell lines (SW480) (Yuan et al., 2011). | Anti-tumor, antiviral, and analgesic agent (Mitrović et al., 2020). |
Suppression of colonic cancer (Zhu et al., 2012). | ||
Origanum majorana L. | Apoptotic and anti-proliferative activity on human lymphoblastic leukemic cell line (Jurkat) (Abdel-Massih et al., 2010). | Treatment of insomnia, gastritis, asthma and nervousness (Singla and Vasudeva, 2015). |
Origanum vulgare L. | Anticancer activity on human lung cancer cell line (A549) (Sankar et al., 2013). | Digestive and circulatory stimulant, antispasmodic, calmative, carminative, diaphoretic, expectorant, stomachic agent (de Torre et al., 2020). |
Hordeum vulgare L. |
Inhibition of oxidative DNA damage and apoptosis (J. B. Jeong et al., 2009). | Treatment of inflammatory, cardiovascular diseases, obesity, diabetes, circulatory disorders, arthritis, anemia, excessive cholesterol levels, renal difficulties, and cancer (Gul et al., 2014), (Thatiparthi et al., 2019). |
Antitumor effect in mammary carcinogenesis (Kubatka et al., 2016). | ||
Vitis vinifera L. | Anticancer effect on liver (HepG2) and cervical (HeLa) cancer cells (Apostolou et al., 2013). | Treatment of diarrhea, hepatitis and stomachaches (Aouey et al., 2016). |
Ephedra alata Decne |
Antiproliferative and pro-apoptotic potential against the MCF-7 breast cancer cell line (Danciu et al., 2018). | Treatment of allergies, asthma, colds, coughs, edema, fever, headaches, and nasal congestion (Mighri et al., 2019). |
Drimia maritima (L.) Stearn | Cytotoxicity on lung cancer cell lines (A549) (Bozcuk et al., 2011). | No data |
Pinus halepensis Mill. | Antiangiogenic activity on adenocarcinoma of human basal epithelial cells (A549), human colon adenocarcinoma (HCT15) and human myeloma (HL60) (Kadri et al., 2014). | Treatment of diarrhea, wounds, rheumatism, cough, gastrointestinal illnesses, hypertension, and hemorrhoids, used also as antiseptic, astringent, antifungal, and anti-tuberculosis (El Omari et al., 2021). |
Urtica dioica L. |
Antiproliferative activity on human prostate cancer cells (LNCaP, hPCPs) (Konrad et al., 2000). | Used as antihypertensive blood purifier, emmenagogue, diuretic, as well as to treat menstrual hemorrhage, rheumatism, and eczema (Testai et al., 2002), (Ilhan et al., 2019) |
Citrus aurantium L. | Induction of G2/M phase arrest and apoptosis in human gastric cancer AGS Cells (Lee et al., 2012). | Treatment of influenza, insomnia, used also as tranquilizer, cardiovascular analeptic, and antispasmodic (Karthikeyan, 2014). |
Induction of the cell cycle arrest and apoptosis in lung cancer cells (A549) (Park et al., 2012). | ||
Cytotoxic effect on human colorectal carcinoma cell line (lim1863) (Odeh et al., 2012). |